Integral Diagnostics Stock Price, News & Analysis (ASX:IDX) Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume240,828 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield4.22%Price TargetN/A About Integral Diagnostics Stock (ASX:IDX)Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.Read More IDX Stock News HeadlinesNovember 23, 2023 | morningstar.comIntegral Diagnostics Ltd IDXNovember 2, 2023 | fool.com.auGuess which ASX All Ords share is crashing 30% todayDecember 2, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 2, 2023 | finance.yahoo.comInvestors in Integral Diagnostics (ASX:IDX) have unfortunately lost 34% over the last three yearsAugust 30, 2023 | finance.yahoo.comIntegral Diagnostics' (ASX:IDX) Dividend Will Be Increased To A$0.035August 28, 2023 | afr.comWhat we learnt: Appen, NextDC, Helloworld, Integral DiagnosticsAugust 20, 2023 | finance.yahoo.comA Look At The Fair Value Of Integral Diagnostics Limited (ASX:IDX)May 23, 2023 | finance.yahoo.comIntegral Diagnostics (ASX:IDX) shareholders have earned a 8.1% CAGR over the last five yearsDecember 2, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. May 8, 2023 | finance.yahoo.comIntegral Diagnostics Limited (ASX:IDX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies AheadMay 8, 2023 | finance.yahoo.comIntegral Diagnostics Limited (ASX:IDX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?April 24, 2023 | finance.yahoo.comIntegral Diagnostics Limited (ASX:IDX) most popular amongst individual investors who own 57% of the shares, institutions hold 32%April 10, 2023 | finance.yahoo.comGreat news for Integral Diagnostics Limited (ASX:IDX): Insiders acquired stock in large numbers last yearMarch 13, 2023 | finance.yahoo.comCalculating The Fair Value Of Integral Diagnostics Limited (ASX:IDX)February 26, 2023 | finance.yahoo.comWhy It Might Not Make Sense To Buy Integral Diagnostics Limited (ASX:IDX) For Its Upcoming DividendFebruary 18, 2023 | finance.yahoo.comIntegral Diagnostics First Half 2023 Earnings: EPS: AU$0.069 (vs AU$0.051 in 1H 2022)February 17, 2023 | fool.com.auWhy Baby Bunting, Integral Diagnostics, Pilbara Minerals, and Zip shares are fallingFebruary 1, 2023 | benzinga.comDigital Diagnostics and Tamer Healthcare Announce Strategic Partnership in the Kingdom of Saudi ArabiaDecember 31, 2022 | fool.comFulgent Genetics (NASDAQ: FLGT)December 22, 2022 | finance.yahoo.comShould You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?November 30, 2022 | finance.yahoo.comIntegral Diagnostics (ASX:IDX) shareholders have endured a 41% loss from investing in the stock a year agoNovember 4, 2022 | finance.yahoo.comInstitutions profited after Integral Diagnostics Limited's (ASX:IDX) market cap rose AU$61m last week butindividual investors profited the mostOctober 7, 2022 | finance.yahoo.comBullish Integral Diagnostics Limited (ASX:IDX) insiders filled their treasuries with AU$810k worth of stock over last yearSeptember 23, 2022 | finance.yahoo.comIs Integral Diagnostics Limited (ASX:IDX) Trading At A 43% Discount?September 17, 2022 | afr.comIntegral Diagnostics LimitedAugust 30, 2022 | fool.com.au3 ASX shares now at a golden buying opportunity: expertsAugust 16, 2022 | reuters.comIntegral Diagnostics LtdSee More Headlines Receive IDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 10/3 Dividend8/30/2023Dividend Payable10/03/2023Today12/02/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolASX:IDX CUSIPN/A CIKN/A Webwww.integraldiagnostics.com.au Phone61 3 5339 0704FaxN/AEmployees2,010Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.11 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.39Net Income$25.04 million Net Margins5.68% Pretax MarginN/A Return on Equity6.95% Return on Assets3.07% Debt Debt-to-Equity Ratio97.86 Current Ratio0.76 Quick Ratio1.84 Sales & Book Value Annual Sales$440.76 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow23.99 Book ValueA$1.60 per share Price / BookN/AMiscellaneous Outstanding Shares233,470,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.95 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Ian Kadish M.B.A. (Age 60)MBBCh, CEO, MD & Director Comp: $930.5kMr. Craig WhiteChief Financial OfficerKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All CompetitorsInsidersIan KadishSold 26,035 sharesTotal: $75,241.15 ($2.89/share)Ian KadishSold 435,572 sharesTotal: $1.35 M ($3.11/share)John AtkinSold 1,680 sharesTotal: $4,646.88 ($2.77/share) IDX Stock Analysis - Frequently Asked Questions How often does Integral Diagnostics pay dividends? What is the dividend yield for Integral Diagnostics? Integral Diagnostics announced a Final dividend on Wednesday, August 30th. Stockholders of record on Tuesday, October 3rd will be paid a dividend of 0.035 per share on Tuesday, October 3rd. This represents a dividend yield of 1.15%. The ex-dividend date is Wednesday, August 30th. This is a positive change from the stock's previous Final dividend of A$0.03. Read our dividend analysis for IDX. Is Integral Diagnostics a good dividend stock? Integral Diagnostics (ASX:IDX) pays an annual dividend of A$0.07 per share and currently has a dividend yield of 4.22%. IDX has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 63.64%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for IDX. What other stocks do shareholders of Integral Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Integral Diagnostics investors own include Gevo (GEVO), Fluidigm (FLDM), EML Payments (EML), electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Chimerix (CMRX), Capricor Therapeutics (CAPR), Bathurst Resources (BRL) and Athersys (ATHX). This page (ASX:IDX) was last updated on 12/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integral Diagnostics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.